Detalhe da pesquisa
1.
Assessment of T Cell Receptor Complex Expression Kinetics in Natural Killer Cells.
Curr Issues Mol Biol
; 44(9): 3859-3871, 2022 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36135177
2.
N-WASP is required for B-cell-mediated autoimmunity in Wiskott-Aldrich syndrome.
Blood
; 127(2): 216-20, 2016 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-26468226
3.
The Rho GTPase Cdc42 Is Essential for the Activation and Function of Mature B Cells.
J Immunol
; 194(10): 4750-8, 2015 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25870239
4.
N-wasp is essential for the negative regulation of B cell receptor signaling.
PLoS Biol
; 11(11): e1001704, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24223520
5.
A novel mouse model for the hyper-IgM syndrome: a spontaneous activation-induced cytidine deaminase mutation leading to complete loss of Ig class switching and reduced somatic hypermutation.
J Immunol
; 193(9): 4732-8, 2014 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25252954
6.
Foxp3 lacking exons 2 and 7 is unable to confer suppressive ability to regulatory T cells in vivo.
J Autoimmun
; 63: 23-30, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26149776
7.
Deletion of WASp and N-WASp in B cells cripples the germinal center response and results in production of IgM autoantibodies.
J Autoimmun
; 62: 81-92, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26143192
8.
Functional Assessment for Clinical Use of Serum-Free Adapted NK-92 Cells.
Cancers (Basel)
; 11(1)2019 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30634595
9.
The Small Rho GTPases Rac1 and Rac2 Are Important for T-Cell Independent Antigen Responses and for Suppressing Switching to IgG2b in Mice.
Front Immunol
; 8: 1264, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29056938
10.
IL-2 in the tumor microenvironment is necessary for Wiskott-Aldrich syndrome protein deficient NK cells to respond to tumors in vivo.
Sci Rep
; 6: 30636, 2016 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27477778
11.
Deletion of Wiskott-Aldrich syndrome protein triggers Rac2 activity and increased cross-presentation by dendritic cells.
Nat Commun
; 7: 12175, 2016 07 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-27425374
12.
Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity.
Front Immunol
; 6: 605, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26648934